Saltar al contenido
Nutrición y metabolismoRevisión de evidencia3 min read

Mediterranean diet and multiple sclerosis: lower odds, but weak evidence overall

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Association between Mediterranean Diet and Development of Multiple Sclerosis: A Systematic Review and Meta-Analysis. · Brain and behavior · 2026 · Artículo original ↗

Idea principal

In a meta-analysis of 8 studies (5 case-control, 3 cohort), high Mediterranean diet adherence was associated with lower odds of multiple sclerosis (fixed-effect OR 0.275, 95% CI 0.11-0.72, p < 0.01), but the cohort studies found no significant relationship. The authors themselves say the evidence is weak because of few studies, retrospective designs, high bias and heterogeneity.

Study design

Revisión de evidencia

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Multiple sclerosis (MS) is a chronic inflammatory disease that damages the myelin of the central nervous system. Evidence on whether following a Mediterranean diet (MedDiet) affects the chance of developing it is conflicting, and no systematic review existed. The authors examined this association.

Población y método

Systematic review and meta-analysis following PRISMA and JBI methods. PubMed, Embase, Web of Science and Scopus were searched up to March 2024 for original clinical studies of MedDiet adherence and MS development. Risk of bias was assessed with JBI critical appraisal tools, and meta-analyses were run in CMA4 software. Of 202 screened records, 8 studies met the criteria: 5 case-control and 3 cohort studies.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Three case-control studies suggested that MedDiet adherence goes with lower odds of MS, while the cohort studies showed no significant relationship.
  2. 2
    In the meta-analysis, high adherence to the MedDiet was associated with lower odds of MS compared with the least adherence (fixed-effect OR 0.275, 95% CI 0.11-0.72, p < 0.01).
  3. 3
    The authors judged that the overall evidence does not strongly support a preventive role for the MedDiet.

Límites e incertidumbre

  1. 1
    Only 8 studies, mostly retrospective case-control, in which diet is recalled after diagnosis and may be biased.
  2. 2
    Several studies had a high risk of bias and the authors observed substantial heterogeneity, yet a fixed-effect model was used for the headline estimate.
  3. 3
    The odds ratio of 0.275 is a large effect that conflicts with the null results of the cohort studies, so it should not be read as the likely true size of any benefit.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

A Mediterranean-style diet has other well-established benefits, but this review does not show that it prevents multiple sclerosis. Anyone with MS concerns or a family history should talk to a clinician rather than rely on diet alone.

Tus datos

Food logs can show how closely your eating matches a Mediterranean pattern, for example vegetables, legumes, fish and olive oil, and you can compare week to week. That tracks diet quality only; there is no personal measurement that tells you your MS risk.

Cómo interpretar la evidencia

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Given the conflicting evidence regarding the impact of adherence to the Mediterranean diet (MedDiet) on MS development and the lack of a systematic review on this topic, this study aimed to examine this association.

Methods

Following the PRISMA and JBI methods, a search of electronic databases was conducted through PubMed, Embase, Web of Science, and Scopus up to March 2024. Clinical original studies assessing the association between the MedDiet adherence and MS development were included. Risk of bias was evaluated using JBI critical appraisal tools. Meta-analyses were performed using CMA4 software.

Results

Out of 202 screened records, eight studies, including five case-control and three cohort studies, met the inclusion criteria. Retrospective evidence from three case-control studies suggested that MedDiet adherence is associated with decreased odds of MS, whereas cohort studies showed no significant relationship. Based on the meta-analysis, there was a significant association between high adherence to the MedDiet and reduced odds of MS (fixed-effect OR: 0.275, 95% CI: 0.11-0.72, p-value <0.01, least MedDiet adherence as the reference).

Discussion

Although the meta-analysis showed a significant inverse association between higher adherence to the MedDiet and the odds of MS, the overall body of evidence does not provide strong support for a preventive role of the MedDiet. Considering the limited number of included studies, the predominantly retrospective design, the high risk of bias in several studies, and the substantial observed heterogeneity, further well-designed prospective studies are needed.

Fuentes y atribución

Association between Mediterranean Diet and Development of Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Shakouri F, Lotfi M, Rostami A, Talebi M, Sanaie S, Naseri A.

Brain and behavior · 2026-02-01

DOI: 10.1002/brb3.71205 ↗PubMed · 41612786 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis de ensayos

Early time-restricted eating linked to more weight loss and lower insulin than late eating

Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.

BMJ Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss

Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain

In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.

Cell Metabolism

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)

Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
Nutrición y metabolismo →